ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,405, issued on Dec. 16, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes viruses" was invented by Andrew John Cooke (Scotland, Great Britain), Brendan M. Crowley (Collegeville, Pa.), Marc A. Labroli (Moorestown, N.J.), Michael Aaron Plotkin (Frenchtown, N.J.), Izzat T. Raheem (Doylestown, Pa.), Ling Tong (Warren, N.J.) and Deyou Sha (Newark, Del.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel Bicyclic Heterocycle Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, X, Y, Z, R1 R5, R6, and R7 a...